ERRATAS

Impact of subclinical hypothyroidism treatment in systolic and diastolic cardiac function: errata

Ricardo Mendes Martins; Regina Helena Alves Fonseca; Marta Maria Turano Duarte; Vaneska Spinelli Reuters; Márcia Martins Ferreira; Cloyra Almeida; Alexandru Buescu; Patrícia de Fátima dos Santos Teixeira; Mario Vaisman

Correção do Artigo

Impact of subclinical hypothyroidism treatment in systolic and diastolic cardiac function

Arq Bras Endocrinol Metab. 2011;55(7):460-7

Na página 463, na table 1, onde se lê:

Tabela 1 - Clique para ampliar

Leia-se:

Tabela 1 - Clique para ampliar

Na página 464, na table 2, onde se lê:

Tabela 2 - Clique para ampliar

Leia-se:

Tabela 2 - Clique para ampliar

Hypertension-related factors in patients with active and inactive acromegaly: errata

Daniela Fedrizzi; Ticiana Costa Rodrigues; Fabíola Costenaro; Rosana Scalco; Mauro Antônio Czepielewski

Correção do Artigo

Hypertension-related factors in patients with active and inactive acromegaly

Arq Bras Endocrinol Metab. 2011;55(7):468-74

No Abstract onde se lê:

CONCLUSIONS: Our findings suggest that blood pressure levels in patients with active acromegaly are very similar, and depend on excess GH. However, once the disease becomes controlled and IGF-1 levels decrease, their blood pressure levels will depend on the other cardiovascular risk factors.

Leia-se:

CONCLUSIONS: Blood pressure (BP) levels in patients with active acromegaly dependent of the GH excess. However, once the disease becomes controlled and IGF-1 levels decrease, their blood pressure levels are depend on the other cardiovascular risk factors.

A rational approach to the diagnosis of polycystic ovarian syndrome during adolescence: errata

Paulina M. Merino; Ethel Codner; Fernando Cassorla

Correção do Artigo

A rational approach to the diagnosis of polycystic ovarian syndrome during adolescence

Arq Bras Endocrinol Metab. 2011;55(8):590-8

Na página 595, primeira coluna, segundo parágrafo onde se lê:

Villarroel and cols. (40), from our group, reported that girls with PCOM have higher AMH levels than girls without PCOM (72.5 ± 6.1 vs. 33.4 ± 2.6 pmol/L; P < 0.0001), and lower FSH levels (5.4 ± 0.3; 6.2 ± 0.2 mUI/ml; P < 0.036).

Leia-se:

Villarroel and cols. (40), from our group, reported that girls with PCOM have higher AMH levels than girls without PCOM (72.5 ± 6.1 vs. 33.4 ± 2.6 pmol/L; P < 0.0001), and lower FSH levels (5.4 ± 0.3 vs. 6.2 ± 0.2 mUI/ml; P < 0.036).

Na página 595, segunda coluna, último parágrafo onde se lê:

In 160 obese adolescents girls, the subgroup with the metabolic syndrome (48 girls) demonstrated significantly higher testosterone and DHEA-S concentrations compared with the 112 girls without MS.

Leia-se:

In 160 obese adolescents girls, the subgroup with the metabolic syndrome (MS) (48 girls) demonstrated significantly higher testosterone and DHEA-S concentrations compared with the 112 girls without MS.

Na página 595, na legenda da figura, onde se lê:

Figure 1.

Leia-se:

Figure 1. Longitudinal study of polycystic ovarian morphology in individual girls at baseline and follow-up. The ultrasonographic status of the 18 girls who participated in the three evaluations is shown at the right; the numbers for the two girls who withdrew from the study are shown on the left. Adapted from "Codner E, et al. Polycystic ovarian morphology in postmenarchal adolescents. Fertil Steril. 2011;95:702-6".

Na página 596, Table 2, onde se lê:

Tabela 2 - Clique para ampliar

Leia-se:

Tabela 2 - Clique para ampliar

Na página 596 onde se lê:

Disclosure: no potential conflict of interest relevant to this article was reported.

Leia-se:

Disclosure: this work was partially supported by Fondecyt Grants 1050452 and 1100123 to Ethel Codner and 1095118 to Fernando Cassorla.

Hormônio de crescimento em crianças e adolescentes com fibrose cística: errata

Pollyana Garcia Amorim; Thaís de Barros Mendes; Lílian Santiago Pinho de Oliveira; Gil Guerra-Júnior; José Dirceu Ribeiro

Correção do Artigo

Impact of subclinical hypothyroidism treatment in systolic and diastolic cardiac function

Hormônio de crescimento em crianças e adolescentes com fibrose cística

Arq Bras Endocrinol Metab. 2011;55(9):671-6

Na página 671 onde se lê:

A fibrose cística (FC) é a doença genética com herança autossômica recessiva mais comum na população de origem caucasiana, afetando cerca de 1 a 2.500 nascidos vivos.

Leia-se:

A fibrose cística (FC) é a doença genética com herança autossômica recessiva mais comum na população de origem caucasiana, afetando cerca de 1 em 2.500 nascidos vivos.

Datas de Publicação

• Publicação nesta coleção
  14 Maio 2012
• Data do Fascículo
  Fev 2012